Metabolic Endpoints for Obstructive Sleep Apnea Following Twelfth Cranial Nerve Stimulation - Trial NCT06317701
Access comprehensive clinical trial information for NCT06317701 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Chicago and is currently Recruiting. The study focuses on Obstructive Sleep Apnea. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Chicago
Timeline & Enrollment
N/A
Apr 04, 2024
Apr 01, 2028
Primary Outcome
Glycemic variability,Mean systolic BP (daytime and nocturnal),Glycemic variability
Summary
The purpose of this study is to determine if the treatment of Obstructive sleep apnea (OSA)
 by hypoglossal nerve stimulation (HGNS) will alter glucose metabolism. The study team will
 also determine if the treatment of Obstructive sleep apnea (OSA) by (hypoglossal nerve
 stimulation) HGNS will alter predictors of cardiovascular outcomes.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06317701
Device Trial